Status
Conditions
Treatments
About
The primary aim of "the Effectiveness of Psychological Interventions for Common mental disorders" (EPIC) randomized controlled trial is to investigate whether a significantly larger symptom improvement is observed after approximately four months of psychotherapeutic treatment in the Danish primary sector compared to in a waiting list control group. The secondary aim of the study is to identify specific client and therapy characteristics that may predict the effectiveness of the therapy or the symptom development in the waiting list control group. The main hypothesis of the EPIC trial is:
1) Four and a half months after randomization, we will find a significantly lower level of symptoms on the primary outcome measure (PHQ-ADS) among clients who receive psychotherapy, compared to clients in the waiting list control group. In addition, we hypothesize to find significantly better outcomes in the psychotherapy group on all secondary outcome measures, four and a half months after randomization.
Researchers will compare:
to investigate whether a larger symptom improvement is observed in the group receiving psychotherapy compared to the waiting list control group.
Participants will:
Full description
Aims:
The primary aim of this randomized controlled trial is to investigate whether a significantly higher symptom improvement is observed after approximately four months of psychotherapeutic treatment in the Danish primary sector compared to a waiting list control group. A supplementary aim is to explore whether the treatment effect is maintained during follow-up assessed approximately eight and 16 months after the beginning of treatment. The secondary aim of the study is to investigate whether specific client and therapy characteristics predicting the effect of the therapy and the symptom change in the waitlist control group can be identified, and whether the quality of the therapeutic alliance measured after approximately five weeks of therapy is related to the outcome of therapy.
The hypotheses of the study are as follows:
Four and a half months after randomization, we will find a significantly lower level of symptoms on the primary outcome measure (PHQ-ADS) among clients who receive psychotherapy, compared to clients in the waiting list control group. In addition, we hypothesize to find significantly better outcomes in the psychotherapy group on all secondary outcome measures, four and a half months after randomization.
We expect that the client's coping strategies, emotion regulation strategies, and level of personality pathology will be significantly related to symptom change and treatment dropout amongst the clients receiving psychotherapy, and to symptom change in the waitlist group, four and a half months after randomization.
We expect that the quality of the working alliance after approximately five weeks of therapy will be significantly related to symptom change on the PHQ-ADS after four and a half months of therapy. Conversely, we do not expect that the therapeutic orientation of the psychologist will be independently related to symptom change after four and a half months of therapy.
We will explore whether the symptom change observed after approximately four and a half months persists eight and a half and 16 and a half months after the beginning of therapy.
Primary Analysis:
- The primary analysis of the general treatment effect in the practice sector will consist of a multilevel longitudinal regression model. This model will assess the difference in the rate of change between the intervention group and the control group in the PHQ-ADS scores over a period of approximately four months of therapy.
Secondary Analyses:
Secondary Predictor Analyses:
All analyses are conducted as intention-to-treat with multiple imputations of missing data.
Study Design:
The study is designed as a pragmatic randomized controlled trial with a block randomization of clients referred by their general practitioner (GP) for psychotherapy treatment in the primary care sector in Denmark. The clients are randomized in a 1:1 allocation ratio to one of the following options:
Participants:
Participants will typically be referred by their GP based on one of 11 referral reasons, which include:
Procedure:
Ethics:
Dissemination of Results:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Clients:
Psychologists:
Exclusion criteria
- Clients considered unfit for participation or urgently needing psychological or medical help, as determined by the therapist.
Primary purpose
Allocation
Interventional model
Masking
308 participants in 2 patient groups
Loading...
Central trial contact
Stig Poulsen, Professor; Celia Faye Jacobsen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal